On September 5th, 2017, IPOPEMA 112 FIZAN made a capital investment into GeniCore Sp. z o.o. This funding will allow for further development and commercialization of GeniCore technologies. The sum of PLN 8 million has been invested and it will enable GeniCore to carry out the key R&D projects necessary. Invest Concept acted as a transaction advisor for GeniCore.

IPOPEMA 112 FIZAN invests in innovative technology companies by providing funding as well as facilitative access to management and commercialization knowledge. The current investments from IPOPEMA 112 FIZAN includes OncoArendi Therapeutics (a biotechnology company specializing in research, development and the commercialization of new drugs used in the treatment of inflammatory and cancer diseases).